•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A07748 Summary:

BILL NOA07748
 
SAME ASSAME AS S04459
 
SPONSORBraunstein
 
COSPNSR
 
MLTSPNSR
 
Amd §3306, Pub Health L
 
Adds W-18 (4-chloro-N-{1-{2-(4-nitrophenyl)ethyl}2piperidinylidene}benzenesulfonamide) to the schedule of controlled substances.
Go to top    

A07748 Actions:

BILL NOA07748
 
04/08/2025referred to health
Go to top

A07748 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A7748
 
SPONSOR: Braunstein
  TITLE OF BILL: An act to amend the public health law, in relation to adding W-18 to the schedule of controlled substances   PURPOSE:: Relates to adding W-18 to the schedule of controlled substances.   SUMMARY OF PROVISIONS:: Section 1: adds W-18 (4-chloro-N-(1-12-(4-nitrophenyflethy1}2- piperidinylidenelbenzenesulfonamide to Subdivision (b) of Schedule I of Section 3306 of the Public Health Law. Section 2: Sets effective date.   JUSTIFICATION:: In recent years, the use of synthetic drugs has become increasingly widespread. These drugs have been created by manufacturers as an alter- native to already-illegal drugs. This legislation would make W18 illegal in order to prevent the potentially harmful results of W18 from reaching New York. W-18, which was banned in Canada in 2016, was originally created as a pain reliever and patented in the United States and Canada in 1984, but was only tested on mice and never sold commercially. The 1984 patent for W-18 indicated that there were no tests which could detect the drug in blood or urine. According to the Canadian Department of Health, ."the use of W-18 as a legal substitute for other controlled substances was first detected in Europe in 2013, in the context of recreational use. In 2014,W-18 was added to the Europe an Monitoring Centre for Drugs and Addiction (EMCDDA) list of New Psychoactive Substances." W-18 first appeared in Canada in 2015 in counterfeit oxycodone tablets. Health Canada also indicates that "the high analgesic potency of W-18...suggests a potential severe risk for overdose" and the drug is being imported from drug labs in China. The Washington Post reported in 2016 that some experts indicate that W-18 is 100 times more potent than fentanyl. and 10,000 times stronger than morphine. A portion of W-18 the size of a grain of salt could potentially be deadly, according to WYSR in Syracuse. While more research is needed to prove the level of toxicity in W-18, police departments in Canada indicate that it has been mixed with heroin and cocaine to create a more dangerous synthetic drug. In March, 2016, a drug dealer in Florida was convicted of smuggling fentanyl and law enforcement found more than 2 1/2 pounds of W-18 at his residence.   LEGISLATIVE HISTORY:: Senate 2017-2018- S5112, Referred to Health 2020 - S5221, Referred to Health 2021-2022- S1774, Referred to Health Assembly 2017-2018- A3030, Referred to Health 2020- A509, Referred to Health 2021-2022- A486, Referred to Health 2023-2024 - A.9485 Referred to Health.   FISCAL IMPLICATIONS:: None.   EFFECTIVE DATE:: This act shall take effect immediately.
Go to top

A07748 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          7748
 
                               2025-2026 Regular Sessions
 
                   IN ASSEMBLY
 
                                      April 8, 2025
                                       ___________
 
        Introduced  by  M.  of  A.  BRAUNSTEIN  -- read once and referred to the
          Committee on Health
 
        AN ACT to amend the public health law, in relation to adding W-18 to the
          schedule of controlled substances
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:

     1    Section 1. Subdivision (b) of schedule I of section 3306 of the public
     2  health law is amended by adding a new paragraph 93 to read as follows:
     3    (93) W-18 (4-chloro-N-{1-{2-(4-nitrophenyl)ethyl}2piperidinyli-
     4  dene}benzenesulfonamide).
     5    § 2. This act shall take effect immediately.
 
 
 
 
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD06982-01-5
Go to top